Related Experiment Video

Updated: Dec 13, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.0K

Emerging Contribution of PancRNAs in Cancer

Neri Mercatelli1, Ramona Palombo1, Maria Paola Paronetto1,2

  • 1Laboratory of Cellular and Molecular Neurobiology, IRCCS Fondazione Santa Lucia, 00143 Rome, Italy.

Cancers
|July 30, 2020
PubMed

Insights

Promoter-associated noncoding RNAs (pancRNAs) are key regulators in cancer development. Understanding pancRNA mechanisms offers new therapeutic strategies for cancer treatment.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Cancer is a complex disease driven by genetic and epigenetic alterations.
  • RNA processing and noncoding RNAs play critical roles in cellular transformation.
  • Promoter-associated noncoding RNAs (pancRNAs) are emerging as significant regulators in oncogenesis.

Purpose of the Study:

  • To review the role of pancRNAs in cancer biology.
  • To discuss recent findings on pancRNAs in cancer risk and progression.
  • To explore the therapeutic potential of targeting pancRNAs.

Main Methods:

  • Computational analysis of RNA processing.
  • Global and quantitative analysis of the cancer transcriptome.
  • Review of current literature on pancRNAs in cancer.

Main Results:

  • Noncoding RNAs, particularly pancRNAs, are crucial in cancer.
  • pancRNAs regulate host genes, including tumor suppressors and oncogenes, in cis.
  • Evidence links pancRNAs to cancer risk and progression.

Conclusions:

  • pancRNAs are integral to cancer biology.
  • Understanding pancRNA molecular mechanisms can lead to novel cancer therapies.
  • pancRNAs represent a promising new class of anticancer drug targets.
Keywords:
RNA binding proteins (RBPs) 3cancer 2cell cycle 4pancRNA 1

More Related Videos

Pancreatic Tissue Dissection to Isolate Viable Single Cells08:04

Pancreatic Tissue Dissection to Isolate Viable Single Cells

Published on: May 26, 2023

3.6K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.2K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.1K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.1K